Cronos Group Inc. (CRON)
Summary
CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?
Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.
Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions
Cronos Group NASDAQ: CRON used its first Investor Day to outline its cultivation, genetics, brand and financial strategy, emphasizing its purpose-built greenhouse partnership with Mucci Farms, continued international expansion and a focus on cash flow generation.
Cronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability
Cronos Group Inc. is upgraded to a Buy, driven by a best-in-class balance sheet and improved profitability. CRON boasts $827 million in cash, no debt, and strong international expansion, with adjusted gross margins reaching 46%. Profitability is supported by disciplined cost management and positive GAAP operating profit, distinguishing CRON from Canadian peers.
Cronos Group Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 62 | $130 | $195.92 | $65.92 | 50.71% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 39,716 | $110,407 | $125,502.56 | $15,095.56 | 13.67% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 2,568 | $6,445.68 | $8,114.88 | $1,669.2 | 25.9% |
| WGS Wilson G. Saville BARRETT & COMPANY Inc. | 750 | $2,085 | $2,445 | $360 | 17.27% |
| NA Nizar Araji National Bank Of Canada /FI/ | 3,564 | $8,945.64 | $11,404.8 | $2,459.16 | 27.49% |
Cronos Group Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| PZ Pablo Zuanic Zelman & Assoc | 20,394.88 | $65,263.62 | $66,134.48 | $870.86 | 1.33% |
Cronos Group Inc. (CRON) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cronos Group Inc. ever had a stock split?
Cronos Group Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Michael Ryan Gorenstein CEO | NASDAQ (NMS) Exchange | 22717L101 CUSIP |
| CA Country | 610 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Cronos Group Inc. stands as a pioneering entity in the cannabinoid industry, dedicating its efforts to the cultivation, production, and distribution of cannabis products across notable markets in Canada, Israel, and Germany. Since its establishment in 2012, the company has positioned itself in Toronto, Canada, navigating the complexities of the ever-evolving cannabis landscape. Through strategic brand development and an unwavering commitment to quality, Cronos Group has carved a niche for itself, becoming synonymous with excellence in the realm of cannabinoid offerings.
Products and Services
- Dried Flower: Cronos Group offers a variety of premium dried cannabis flowers, catering to the traditional cannabis consumer. These products are carefully cultivated to ensure the highest quality and potency, meeting the diverse preferences and needs of their clientele.
- Pre-rolls: For those seeking convenience without compromising on quality, Cronos Group's pre-rolled cannabis offers an easy-to-use option. Expertly rolled from their top-quality dried flower, these pre-rolls provide a consistent and satisfying experience for both new and seasoned users.
- Oils: Cannabis oils by Cronos Group are extracted using state-of-the-art techniques to ensure purity and potency. These oils are versatile, designed for consumptions such as ingestion or topical application, catering to a wide range of medicinal and recreational uses.
- Vaporizers: Recognizing the growing demand for smoke-free alternatives, Cronos Group offers high-quality cannabis vaporizers. These devices are designed for convenient and discreet use, providing a modern approach to cannabis consumption.
- Edibles: Catering to the evolving tastes of their consumer base, Cronos Group has ventured into the world of cannabis-infused edibles. This range includes various ingestible forms, offering a delicious and controlled way to experience the effects of cannabis.
- Cannabis Tinctures: For those preferring direct ingestion or alternative application methods, Cronos Group's cannabis tinctures offer a potent and precise dosing solution. These liquid extracts can be consumed directly or mixed with food or drinks, providing flexibility in usage.
The product lineup is marketed under distinguished brands such as Spinach, Lord Jones, and PEACE NATURALS, each carrying a unique identity and clientele focus, thus allowing Cronos Group to cater to a broad spectrum of consumer needs and preferences.
Contact Information
